Emergent BioSolutions Inc.: Emergent BioSolutions to Participate in First Quarter 2017 Investor Conferences

Tickers: EBS
GAITHERSBURG, Md., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company's senior management team will participate in the following investor conferences during the first quarter of 2017.

  • 35 Annual J.P. Morgan Healthcare Conference
    San Francisco, CA
    January 9-12, 2017
    Presentation: January 10, 2017
  • Wells Fargo Specialty and Generic Drug Summit
    Orlando, FL
    February 13, 2017
    Presentation time TBD
  • Cowen & Co. 37 Annual Health Care Conference
    Boston, MA
    March 6-8, 2017
    Presentation day and time TBD
Presentation dates and times will be updated on the Emergent website www.emergentbiosolutions.com under 'Investors' as this information becomes available.

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
International Business Machines Corporation
For these conferences, the company will be webcasting its presentation, which may include a discussion of the company's recent business developments as well as its most recently reported financial results and guidance. The webcasts will be available both live and by replay, accessible from the Emergent website.

About Emergent BioSolutions
Emergent BioSolutions is a global specialty biopharmaceutical company dedicated to one simple mission-to protect and enhance life. We develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us @emergentbiosolu.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
BurrowsR@ebsi.com

Media Contact:
Tracey Schmitt Lintott
Senior Vice President, Global Public Affairs
240-631-3394
SchmittT@ebsi.com
Emergent BioSolutions Inc.

Emergent BioSolutions Inc. published this content on 29 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 29 December 2016 21:22:05 UTC.